Canntab Therapeutics Limited announced earnings results for the second quarter ended November 30, 2019. For the second quarter, the company announced operating loss was CAD 625,510 compared to CAD 797,334 a year ago. Net loss was CAD 623,102 compared to CAD 787,396 a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago. For the half year, operating loss was CAD 1.069 million compared to CAD 1.265 million a year ago. Net loss was CAD 1.062 million compared to CAD 1.234 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.05 a year ago.